I agree that this site is using cookies. You can find further informations here.
X
Mellinghoff, Ingo K.
299  results:
Search for persons X
?
1

Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cel..:

Pourmaleki, Maryam ; Jones, Caitlin J. ; Mellinghoff, Sabrina D....
Clinical Cancer Research.  , 2024
Link: https://doi.org/10.1158/..
 
?
2

The biological significance of tumor grade, age, enhancemen..:

van den Bent, Martin J ; French, Pim J ; Brat, Daniel...
Neuro-Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Author Correction: Vorasidenib and ivosidenib in IDH1-mutan..:

Mellinghoff, Ingo K. ; Lu, Min ; Wen, Patrick Y....
Nature Medicine.  30 (2023)  1 - p. 302-302 , 2023
Link: https://doi.org/10.1038/..
 
?
4

Moving Spatially Resolved Multiplexed Protein Profiling tow..:

Pourmaleki, Maryam ; Socci, Nicholas D. ; Hollmann, Travis J..
Cancer Discovery.  13 (2023)  4 - p. 824-828 , 2023
Link: https://doi.org/10.1158/..
 
?
5

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma:..:

Mellinghoff, Ingo K. ; Lu, Min ; Wen, Patrick Y....
Nature Medicine.  29 (2023)  3 - p. 615-622 , 2023
Link: https://doi.org/10.1038/..
 
?
6

Integrated clinical and genomic analysis identifies driver ..:

Chatila, Walid K. ; Walch, Henry ; Hechtman, Jaclyn F....
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY..:

McBain, Catherine ; Mellinghoff, Ingo K ; van den Bent, Martin J...
Neuro-Oncology.  25 (2023)  Supplement_3 - p. iii6-iii6 , 2023
Link: https://doi.org/10.1093/..
 
?
8

CDKN2A/B mutations and allele-specific alterations stratify..:

Hickman, Richard A. ; Gedvilaite, Erika ; Ptashkin, Ryan...
Acta Neuropathologica.  146 (2023)  6 - p. 845-847 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Hypothetical generalized framework for a new imaging endpoi..:

Ellingson, Benjamin M ; Gerstner, Elizabeth R ; Lassman, Andrew B...
Neuro-Oncology.  , 2022
Link: https://doi.org/10.1093/..
 
?
10

Isocitrate Dehydrogenase Mutant Grade II and III Glial Neop..:

Mellinghoff, Ingo K. ; Chang, Susan M. ; Jaeckle, Kurt A..
Hematology/Oncology Clinics of North America.  36 (2022)  1 - p. 95-111 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Routine use of low-dose glucarpidase following high-dose me..:

Schaff, Lauren R. ; Lobbous, Mina ; Carlow, Dean...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

Phase III trial of chemoradiotherapy with temozolomide plus..:

Lim, Michael ; Weller, Michael ; Idbaih, Ahmed...
Neuro-Oncology.  24 (2022)  11 - p. 1935-1949 , 2022
Link: https://doi.org/10.1093/..
 
?
13

Combination Olaparib and Temozolomide for the Treatment of ..:

Schaff, Lauren R. ; Kushnirsky, Marina ; Lin, Andrew L....
Neurology.  99 (2022)  17 - p. 750-755 , 2022
Link: https://doi.org/10.1212/..
 
?
14

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society fo..:

Miller, Julie J ; Gonzalez Castro, L Nicolas ; McBrayer, Samuel...
Neuro-Oncology.  25 (2022)  1 - p. 4-25 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Clinical and Pathologic Determinants of Outcome for Non-Opt..:

Piotrowski, Anna F. ; Campian, Jian L. ; Brown, Rebecca...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
1-15